Insider trading · Q3 2026 · CIK 1639691

LivaNova PLC (LIVN) insider trading.

In Q3 2026, insiders at LivaNova PLC reported 7 non-derivative transactions on 7 Forms 3, 4 and 5: 0 open-market purchases and 4 sales worth $800K.

Transactions
7
Purchases (P)
0
Sales (S)
4
Net shares, P minus S
-10,125
Insiders
3
Last filed
2026-09-14

Insiders

InsiderRelationshipTransactionsBuysSales
Tezel AhmetOfficer · Chief Innovation Officer401
Bianchi FrancescoDirector202
Story BrookeDirector101

Transactions

7 non-derivative rows, newest transaction first. Shares and prices as filed.
DateInsiderCodeSharesPriceOwned afterFiling
2026-09-10Bianchi FrancescoS (D)3,500$78.014,434Form 4
2026-09-04Story BrookeS (D)2,300$81.427,488Form 4
2026-08-31Bianchi FrancescoS (D)1,650$79.727,934Form 4
2026-08-11Tezel AhmetF (D)1,428$77.868,765Form 4
2026-08-11Tezel AhmetD (D)8,589$77.8610,193Form 4
2026-08-11Tezel AhmetS (D)2,675$77.746,090Form 4
2026-08-11Tezel AhmetM (A)12,692$52.6818,782Form 4

Transaction codes in this quarter

Get LIVN insider transactions through the API

Request with your API key
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1639691&limit=100" \
  -H "Authorization: Bearer $SEC_API_KEY"

Insider trading API guide · LIVN company page · LivaNova PLC on SEC.gov

Questions

Are insiders buying or selling LivaNova PLC (LIVN)?

In Q3 2026, insiders at LivaNova PLC reported 7 non-derivative transactions on 7 Forms 3, 4 and 5: 0 open-market purchases and 4 sales worth $800K. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.

Where do these LivaNova PLC insider trades come from?

From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.

Source: SEC Insider Transactions Data Sets, Q3 2026, retrieved 2026-10-27. Footnotes, derivative holdings and amendments are in the linked filings. Not investment advice.

Plain-text version for agents and LLMs: /insider-trading/livn.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.